Considerable changes have occurred in the management of differentiated thyroid cancer
(DTC) during the past four decades, based on improved knowledge of the biology of DTC …

Thyroid cancer is the most common endocrine malignancy, although representing fewer
than 1% of all human tumors. Differentiated thyroid carcinoma (DTC) includes the papillary …

Differentiated thyroid cancer (DTC) is a rare malignant disease, although its incidence has
increased over the last few decades. It derives from follicular thyroid cells. Generally …

Context: Initial treatments for patients with differentiated thyroid cancer are supported
primarily by single-institution, retrospective studies, with limited follow-up and low event …

Thyroid cancer is increasing all over the world. The exact cause of this increase is still
debated and there are conflicting reports. Sophisticated molecular studies suggest that …

Differentiated thyroid cancer, which includes papillary and follicular histologies, is a common
malignancy and is increasing in incidence. It carries a favorable prognosis compared to …

Thyroid cancer can be largely classified as well-differentiated, poorly differentiated,
medullary and anaplastic. Differentiated thyroid cancer (DTC) includes follicular and …

Background The study evaluates clinical presentation and outcome of differentiated thyroid
cancer (DTC) on a large series of patients homogeneously managed. Patients and methods …

Context Low-risk differentiated thyroid cancer (DTC) is overdiagnosed, but true incidence
has increased as well. Owing to its excellent prognosis with low morbidity and mortality …

Spectrum of Behavior.-The clinical behavior of well-differentiated-papillary and follicular-
thyroid carcinoma has become increasingly clearer in recent years. Almost all physicians …